PPARA and metabolic dysfunction-associated steatohepatitis: However, it was challenging to understand the therapeutic mechanisms underlying the effects of telmisartan on NASH, and the interaction between angiotensin II receptors and the PPAR signaling pathway, using only transcriptional-regulated genes.